HK1087027A1 - Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain - Google Patents

Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain

Info

Publication number
HK1087027A1
HK1087027A1 HK06107281A HK06107281A HK1087027A1 HK 1087027 A1 HK1087027 A1 HK 1087027A1 HK 06107281 A HK06107281 A HK 06107281A HK 06107281 A HK06107281 A HK 06107281A HK 1087027 A1 HK1087027 A1 HK 1087027A1
Authority
HK
Hong Kong
Prior art keywords
oxazinoä3
aüindole
derivatives
treatment
neuropathic pain
Prior art date
Application number
HK06107281A
Other languages
English (en)
Inventor
Angelo Guglielmotti
Lorenzo Polenzani
Alessandra Alisi
Nicola Cazzolla
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1087027A1 publication Critical patent/HK1087027A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK06107281A 2003-07-18 2006-06-28 Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain HK1087027A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001467A ITMI20031467A1 (it) 2003-07-18 2003-07-18 Farmaco attivo nel dolore neuropatico
PCT/EP2004/007633 WO2005014001A1 (en) 2003-07-18 2004-07-08 Use of 2h- [1, 3] - oxazino [3, 2-a] indole derivatives for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
HK1087027A1 true HK1087027A1 (en) 2006-10-06

Family

ID=34131193

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06107281A HK1087027A1 (en) 2003-07-18 2006-06-28 Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain

Country Status (21)

Country Link
US (1) US20060211691A1 (de)
EP (1) EP1646391B1 (de)
JP (1) JP2006528142A (de)
KR (1) KR20060033784A (de)
CN (1) CN100409850C (de)
AR (1) AR045993A1 (de)
AT (1) ATE345137T1 (de)
AU (1) AU2004262876B2 (de)
CA (1) CA2526852C (de)
DE (1) DE602004003252T2 (de)
DK (1) DK1646391T3 (de)
EA (1) EA008927B1 (de)
ES (1) ES2276317T3 (de)
GE (1) GEP20084307B (de)
HK (1) HK1087027A1 (de)
IL (1) IL172156A0 (de)
IT (1) ITMI20031467A1 (de)
PL (1) PL1646391T3 (de)
PT (1) PT1646391E (de)
UA (1) UA81050C2 (de)
WO (1) WO2005014001A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2103305B1 (de) * 2006-12-26 2011-09-28 Taiho Pharmaceutical Co., Ltd. Therapeutisches mittel gegen diabetische neuropathie
DE102007058504A1 (de) 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189041A (en) * 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
GB9120628D0 (en) * 1991-09-27 1991-11-06 Fujisawa Pharmaceutical Co Pyrrolobenzoxazine derivatives and process for preparation thereof
RU2104279C1 (ru) * 1992-03-12 1998-02-10 Смитклайн Бичам Плс Конденсированное индольное производное или его фармацевтически приемлемая соль, фармацевтическая композиция, проявляющая активность антагониста 5-нт*004-рецептора
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
BR0012934A (pt) * 1999-08-04 2003-07-29 Icagen Inc Processos para a redução de dor e de ansiedade
US20040038874A1 (en) * 2002-08-22 2004-02-26 Osemwota Omoigui Method of treatment of persistent pain

Also Published As

Publication number Publication date
WO2005014001A1 (en) 2005-02-17
KR20060033784A (ko) 2006-04-19
WO2005014001A9 (en) 2005-05-26
EA008927B1 (ru) 2007-08-31
CA2526852C (en) 2011-08-30
ES2276317T3 (es) 2007-06-16
JP2006528142A (ja) 2006-12-14
CA2526852A1 (en) 2005-02-17
DE602004003252T2 (de) 2007-05-03
CN1809361A (zh) 2006-07-26
US20060211691A1 (en) 2006-09-21
ATE345137T1 (de) 2006-12-15
EA200600270A1 (ru) 2006-06-30
DE602004003252D1 (de) 2006-12-28
EP1646391B1 (de) 2006-11-15
DK1646391T3 (da) 2007-03-19
PT1646391E (pt) 2007-01-31
AU2004262876A1 (en) 2005-02-17
ITMI20031467A1 (it) 2005-01-19
CN100409850C (zh) 2008-08-13
PL1646391T3 (pl) 2007-04-30
AU2004262876B2 (en) 2010-05-20
EP1646391A1 (de) 2006-04-19
AR045993A1 (es) 2005-11-23
IL172156A0 (en) 2006-04-10
UA81050C2 (en) 2007-11-26
GEP20084307B (en) 2008-02-11

Similar Documents

Publication Publication Date Title
EP1689485A4 (de) Kardioelektromagnetische behanldung
GB0213869D0 (en) The treatment of pain
GB0330049D0 (en) The treatment of neuropathic pain conditions
IL172101A0 (en) Use of indazole derivatives for the treatment of neuropathic pain
HK1087027A1 (en) Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain
GB0300428D0 (en) Medical treatment
GB0307472D0 (en) Medical treatment
GB0327493D0 (en) Treatment medicament
GB0306165D0 (en) Medical treatment
GB0325957D0 (en) The treatment of pain
SI1646387T1 (sl) Uporaba indazolnih derivatov za zdravljenje nevropaticne bolecine
GB0702858D0 (en) Dressinf for tissue treatment
AU2003210347A1 (en) Cathepsin y for the treatment of pain
GB0322014D0 (en) The treatment of pain
GB0322015D0 (en) The treatment of neuropathic pain conditions
GB0306644D0 (en) Medical treatment
GB0301522D0 (en) Medical treatment
GB0306626D0 (en) Medical treatment
GB0301529D0 (en) Medical treatment
GB0306654D0 (en) Medical treatment
GB0306651D0 (en) Medical treatment
GB0306650D0 (en) Medical treatment
GB0306582D0 (en) Medical treatment
GB0301527D0 (en) Medical treatment
GB0306640D0 (en) Medical treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120708